Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study

Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT01859481
Collaborator
(none)
971
148
3
24
6.6
0.3

Study Details

Study Description

Brief Summary

Evaluation of headache response at 2 hours for active treated attacks for increasing dose.

Condition or Disease Intervention/Treatment Phase
  • Drug: Placebo
  • Drug: Eletriptan HBr 40 mg
  • Drug: Eletriptan HBr 80 mg
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
971 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
A Multicentre, Dose Optimisation Study to Assess the Consistency of Efficacy of Eletriptan for the Treatment of Migraine (With and Without Aura)
Study Start Date :
Mar 1, 2000
Actual Primary Completion Date :
Mar 1, 2002
Actual Study Completion Date :
Mar 1, 2002

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Placebo

Drug: Placebo
All subjects will receive open label eletriptan 40 mg per attack for the first three attacks in the phase 1 of the study. For the next 4 attacks subjects will be assigned to either eletriptan 40 mg or 80 mg group based on the response in the phase 1 portion of the study. In phase II, in each group subjects will receive eletriptan 40 mg or 80 mg for 3 attacks and placebo for 1 attack. In each group double-blind placebo will be inserted at random.

Experimental: Eletriptan HBr 40 mg

Drug: Eletriptan HBr 40 mg
All subjects will receive open label eletriptan 40 mg per attack for the first three attacks in the phase 1 of the study. For the next 4 attacks subjects will be assigned to either eletriptan 40 mg or 80 mg group based on the response in the phase 1 portion of the study. In phase II, in each group subjects will receive eletriptan 40 mg or 80 mg for 3 attacks and placebo for 1 attack. In each group double-blind placebo will be inserted at random.

Experimental: Eletriptan HBr 80 mg

Drug: Eletriptan HBr 80 mg
All subjects will receive open label eletriptan 40 mg per attack for the first three attacks in the phase 1 of the study. For the next 4 attacks subjects will be assigned to either eletriptan 40 mg or 80 mg group based on the response in the phase 1 portion of the study. In phase II, in each group subjects will receive eletriptan 40 mg or 80 mg for 3 attacks and placebo for 1 attack. In each group double-blind placebo will be inserted at random.

Outcome Measures

Primary Outcome Measures

  1. Consistency of headache response (3 responses out of 3 active treated attacks) . Headache response was defined as migraine headache pain of moderate or severe intensity pre dose becoming basent or mild within 2 hours post dose. [24 weeks]

Secondary Outcome Measures

  1. Consistency of headache response (2 responses out of 3 active treated attacks). Headache response was defined as migraine headache pain of moderate or severe intensity pre dose becoming basent or mild within 2 hours post dose. [24 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male and Female subjects in good general health, aged 18 to 65 years.

  • Subjects should meet IHS diagnostic criteria for migraine with or without aura.

  • Based on past history, subjects should expect to suffer at least one acute attack of migraine with or without aura, each 6 weeks

Exclusion Criteria:
  • Known coronary-artery disease, clinically significant arrhythmia, heart failure, or uncontrolled hypertension.

  • Pregnant or lactating women.

  • Clinically significant electrocardiogram abnormalities at screening.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eeuwfeestkliniek Antwerpen Belgium 2018
2 A.Z. Sint Jan Brugge Belgium 8000
3 Cliniques Universitaires St Luc Bruxelles Belgium 1200
4 C.H.U. de Charleroi Charleroi Belgium 6000
5 Hopital de La Citadelle Liege Belgium 4000
6 Faculty Hospital U Svety Anny Brno Czechia 65691
7 Neurologika Klinika F.N. Hradec Kralove Czechia 50005
8 Pain Centrum Prague 2 Czechia 12 850
9 1St Medical Faculty of the Charles University Prague 2 Czechia 12000
10 Arhus Kommunehospital Arhus C Denmark 8000
11 Kas Glostrup Glostrup Denmark 2600
12 Korsgaard, Anne G. (Private Practice) Odense C Denmark 5000
13 Peter Staehr Olstykke Denmark 3650
14 Asbjorn Ziebel Roskilde Denmark 4000
15 Hopital de Rangueil Toulouse Cedex 04 France 31403
16 Veyrie-Courtade Toulouse Tououse France 31500
17 C.H.U.R Bretonneau Tours Cedex Tours France 37044
18 Kubler Altkirch Altkirch France 68130
19 Marcombes Angouleme Angouleme France 16000
20 Houdart Anzin Anzin France 59416
21 Groupe Pellegrin Tripode Bordeaux Cedex France 33076
22 Siboni Carcassonne Carcassonne France 11000
23 Hopital Louis Mourier Colombes Cedex France 92701
24 Cormier Laval Laval France 53000
25 Hopital Salengro Lille France 59037
26 Hopital Louis Pradel Lyon Cedex 03 France 69394
27 Hopital Pasteur Nice Cedex 1 France 06200
28 Private Practice Orleans France 45000
29 Hopital Cochin Paris Codex 14 France 75679
30 Delfiner Paris Paris France 75015
31 Hopital Lariboisiere Paris France 75475
32 Vaunaize Reims (Ds For Oc) Reims France 51100
33 Vaunaize Reims Reims France 51100
34 Hopital Charles Nicolle Rouen France 76031
35 Hospital Bellevue Saint Etienne Cedex 2 France 42055
36 Bouchacourt Toulon Toulon France 83 000
37 Lemarquis Toulon Toulon France 83000
38 Mick Voiron Voiron France 38500
39 Private Practice Berlin Germany 10117
40 Private Practice Berlin Germany 12687
41 Private Practice (Guenther Schumann) Bochum Germany 44805
42 Private Practice Bochum Germany 44807
43 Private Practice Eckernfoerde Germany 24340
44 Private Practice Goettingen Germany 37073
45 Private Practice Hamburg Germany 22149
46 Private Practice Oldenburg Germany 26131
47 Fachklinik Fuer Neurologie Dietenbronn Gmbh Schwendi Germany 88475
48 Private Practice (Dr. Renate Kreyer) Stade Germany 21680
49 Neurology Clinic of Chania Souda Chania,crete Greece 73100
50 General Athens State Hospital Athens Greece GR 156 69
51 Saint Dimitrios Hospital Thessaloniki Greece GR 546 34
52 Peterfy Teaching Hospital Budapest Hungary 1076
53 Semmelweis University Budapest Hungary 1083
54 Szent-Imre Hospital Budapest Hungary 1115
55 Jahn Ferenc Hospital Budapest Hungary 1201
56 Uzsoki Hospital Budapest Hungary 1426
57 University of Debrecen, Medical and Health Science Centre, Medical School Debrecen Hungary 4012
58 Kenezy County Hospital Debrecen Hungary 4034
59 Universita Degli Studi Di Modena-Policlinico Dipartimento Di Medicina Interna Modena Emilia-romagna Italy 41100
60 Fondazione Istituto Neurologico Casimiro Mondino Istituto Di Ricovero E Cura A Carattere Scientifico Pavia Lombardia Italy 27100
61 Universita' Di Bologna Bologna Italy 40123
62 Poliambulatorio Salus Brescia Italy 25100
63 Universita' Degli Studi Di Cagliari - Presidio Osp.S.Giovanni Di Dio Cagliari Italy 09124
64 Azienda Vittorio Emanuele Catania Italy 95100
65 Clinica Neurologica L'aquila-coppito Italy 67100
66 Policlinico Universitario Messina Italy 98125
67 Centro Cefalee Irccs "C. Besta" Milano Italy 20133
68 Universita Di Padova Padova Italy 35128
69 Centro Cefalee Parma Italy 43100
70 Clinica Neurologica, Universita Di Perugia Perugia Italy 06126
71 Centro Cefalee - Neuromed Pozzilli (isernia) Italy 86077
72 Ospedale S. Eugenio Roma Italy 00100
73 Centro Cefalee Torino Italy 10126
74 Ospedale Regionale Torrette Torrette DI Ancona (AN) Italy 60020
75 Ospedale Maggiore Trieste Italy 34126
76 Ospedale S. Bortolo Vicenza Italy 36100
77 Bosch Medicentrum (Locatie Willem Alexander Ziekenhuis) 's-hertogenbosch Netherlands 5223GV
78 Sint Lucas Andreas Ziekenhuis (Location: St.Lucas) Amsterdam Netherlands 1061 AE
79 Gelre Ziekenhuis (Location: Lukas) Apeldoorn Netherlands 7334 DZ
80 Ziekenhuis Gooi-Noord Blaricum Netherlands 1261 AN
81 Ignatius Ziekenhuis Breda Breda Netherlands 4818 CK
82 Gelderse Vallei Ziekenhuis EDE Netherlands 6711 PV
83 Scheperziekenhuis Emmen Netherlands 7824 AA
84 Atrium Heerlen Heerlen Netherlands 6419 PC
85 St. Streekziekenhuis Midden Twente Hengelo (OV) Netherlands 7555DL
86 Ikazia Ziekenhuis Rotterdam Netherlands 3083 AN
87 Sint Elisabeth Ziekenhuis Venray Netherlands 5801 CE
88 Lage Land Ziekenhuis Zoetermeer Netherlands 2725 NA
89 Sentralsykehuset I Akershus Nordbyhagen Norway 1474
90 Volvat Medisinske Senter Oslo Norway 0303
91 Strandquist, Dr. Stein Bror Tonsberg Norway 3111
92 Hospital Garcia Da Orta Almada Portugal 2800
93 Centro Hospitalar de Coimbra Coimbra Portugal 3000
94 Hospital S.Joao Porto Portugal 4000
95 Consorci Hospitalari Del Parc Tauli Sabadell Barcelona Spain 08208
96 Hospital Universitario de Puerto Real Puerto Real Cadiz Spain 11510
97 Fundacion Hospital Alcorcon Alcorcon Madrid Spain 28922
98 Hospital de Galdakao Galdakao Vizcaya Spain 48960
99 Hospital Torrecardenas Almeria Spain 04009
100 Hospital Del Sagrado Corazon Barcelona Spain 08029
101 Hospital General Universitari Vall D�Hebron Barcelona Spain 08035
102 Hospital General Yag� Burgos Spain 09005
103 Hospital Nuestra SE�Ra de Alarcos Ciudad Real Spain 13002
104 Hospital Ciudad de Jaen Jaen Spain 23007
105 Hospital Universitari de Lleida Arnau de Vilanova Lleida Spain 25198
106 Hospital Ramon Y Cajal Madrid Spain 28034
107 Hospital Universitario San Carlos Madrid Spain 28040
108 Hospital Virgen de La Victoria Malaga Spain 29010
109 Hospital General Universitario J. M. Morales Meseguer Murcia Spain 30008
110 Hospital General de Asturias Oviedo Spain 33006
111 Hospital Na Sa de Aranzazu San Sebastian Spain 20014
112 Hospital Nuestra SE�Ra de Valme Sevilla Spain 41014
113 Hospital Clinico Universitario La Fe Valencia Spain 46009
114 Hospital General Universitario Valencia Spain 46014
115 Fritsla Vardcentral Fritsla Sweden 510 29
116 Migranklinik-Goeteborg Goeteborg Sweden SE-411 17
117 Lanssjukhuset Halmstad Halmstad Sweden 301 85
118 Viktoriakliniken Halmstad Sweden 30246
119 Neurologsektionen, Lasarettet Helsingborg Sweden 251 87
120 Neuro Kliniken, Helsingborg Helsingborg Sweden 25221
121 Sjocrona Vardcentral Hoganas Sweden 263 26
122 Huddinge Universitetssjukhus Huddinge Sweden
123 Kistahalsan Ab Kista Sweden 164 40
124 Lund Lakarmottagningen Lund Sweden 221 21
125 Medicin Kliniken, Universitetssjukhuset Lund Sweden 22185
126 Lakargruppen Gustaf Adolf Malmo Sweden 211 36
127 Previa Ab Sigtunahalsan Marsta Sweden 195 30
128 Oxelohalsan Oxelosund Sweden 613 30
129 Bankhalsan Stockholm Sweden 105 34
130 Lakarhuset Odenplan Stockholm Sweden 113 22
131 Ostermalmshalsan Stockholm Sweden 11486
132 St Gorans Sjukhus Stockholm Sweden SE-112 81
133 Tyresohalsan Huslakare Ab (Ds For Oc) Tyreso Sweden 135 21
134 Tyresohalsan Huslakare Ab Tyreso Sweden 135 21
135 Kronobergskliniken Vaexjoe Sweden SE-352 34
136 Centrallasarettet Vasteras Sweden 721 89
137 Vasterviks Sjukhus Vastervik Sweden 593 81
138 Novakliniken Ystad Sweden 271 39
139 Cukurova University Medical Faculty Adana Turkey 01330
140 Karadeniz Technical University Medical Faculty Trabzon Turkey 61080
141 Ahepa University Hospital
142 Foretagshalsovarden Linden
143 Huslakargruppen
144 Limhamns Lakargrupp, Tarnan
145 Medicinskt Centrum
146 Sentralsjukehuset I Hedmark
147 Sint Anna Ziekenhuis
148 Vardcentralen

Sponsors and Collaborators

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Investigators

  • Study Director: Pfizer CT.gov Call Center, Pfizer

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
ClinicalTrials.gov Identifier:
NCT01859481
Other Study ID Numbers:
  • A1601015
First Posted:
May 22, 2013
Last Update Posted:
Jan 27, 2021
Last Verified:
Jan 1, 2021

Study Results

No Results Posted as of Jan 27, 2021